Research Progress of the Resistance Mechanism of Non-small Cell Lung Cancer 
to EGFR-TKIs

Research Progress of the Resistance Mechanism of Non-small Cell Lung Cancer 
to EGFR-TKIs

Nowadays, lung cancer is the malignant tumor of the highest morbidity and mortality over the world, and non-small cell lung cancer (NSCLC) makes up about 80%. There is a great many NSCLC patients have been in advanced stage when diagnosed. As a result, people pay more attention to curing advanced NS...

Full description

Bibliographic Details
Main Authors: Huihui LIU, Mengzhao WANG, Ke HU, Yan XU, Manjiao MA, Wei ZHONG, Jing ZHAO, Longyun LI, Huazhu WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2013-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
EGFR
EGFR-TKIs
Resistance
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2013.10.07

Similar Items

Similar Items